Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:dTTP)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001680 AN002739 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine Abundance
ST001986 AN003237 Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells T-cells Mouse University of Cambridge arbitrary unit
ST003020 AN004954 Polar metabolite levels in MEL cells following PKC inhibition in 2,000 nM or 100 nM FA conditions Cultured cells Mouse Anemia Boston Children's Hospital, Harvard Medical School Arbitrary Units
ST003107 AN005086 Characterization of metabolic changes upon FGFR inhibition in ICC13-7 Xenograft Cultured cells Mouse Cancer Massachusetts General Hospital area analyzed by Compound Discoverer (counts x seconds)
ST002708 AN004390 Levels of central carbon metabolites in choroid plexus as part of natural diurnal variation Brain Mouse Circadian Rhythm Disorder Boston Childrens Hospital a.u.
ST003082 AN005040 Metabolome changes in embryonic CSF (Part 4) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST003083 AN005041 Metabolome changes in embryonic CSF (Part 5) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST002234 AN003644 A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis Cultured cells Human DNA damage response CRG au
ST002123 AN003476 GCN2 regulates mitochondrial OXPHOS in HSPCs under proliferation conditions. Bone marrow Mouse Sun Yat-sen University AU
ST001074 AN001756 Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Parasite Human Pennsylvania State University Average Peak Area
ST002187 AN003581 Interplay of CodY and CcpA in regulating central metabolism and biofilm formation in S. aureus Bacterial cells S. aureus Bacterial infection University of Nebraska Medical Center CPS
ST001788 AN002900 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University Intensity
ST001188 AN001980 P. falciparum infected erythrocytes Cultured cells Plasmodium falciparum Malaria University of Melbourne ion count
ST002119 AN003468 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University ion counts
ST000441 AN000692 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways Plasmodium cells Plasmodium falciparum Malaria Pennsylvania State University log2 fold change vs untreated
ST001350 AN002246 Extraction of high-resolution Metabolomics data of the Yeast Metabolic Cycle Yeast cells Yeast University of Florida nmol/mg protein
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Fungi Malaria Pennsylvania State University Normalized and blank subtracted peak area
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Normalized and blank subtracted peak area
ST002969 AN004878 Polar metabolites in cecal tissue of mice treated with or without ampicillin and tributyrin Cecum Mouse Bacterial infection The Rockefeller University Normalized Area
ST000133 AN000215 1H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen Spleen Mouse Cancer Pacific Northwest National Laboratory normalized conc. (uM/mg)
ST002009 AN003275 Metabolomics analysis of stress erythroid progenitors Stem cells Mouse Inflammation Pennsylvania State University Normalized peak area
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003387 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003388 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003390 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002205 AN003608 Effect of Hira loss in the metabolic landscape of Fh1-deficient cells Cultured cells Mouse Cancer CECAD Research Center, University Hospital Cologne peak area
ST002218 AN003627 Effect of Hira loss in the metabolic landscape of Fh1-deficient cells Part 2 Cultured cells Mouse Cancer CECAD Research Center peak area
ST002221 AN003630 Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002222 AN003631 Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002224 AN003633 Intracellular metabolic profile of renal cells cultured in Plasmax Cultured cells Human Cancer CECAD Research Center peak area
ST002225 AN003634 Time sensitive contribution of the BCAA catabolism to the TCA cycle carbons in HK2, 786-O, OS-RC-2 and RFX-631 Cultured cells Human Cancer CECAD Research Center peak area
ST002906 AN004769 Polar metabolite levels in K562 cells following short-term folate depletion Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School peak area
ST002912 AN004782 Polar metabolite levels in MEL cells following folate depletion Cultured cells Mouse Anemia Boston Children's Hospital, Harvard Medical School peak area
ST002913 AN004783 Polar metabolite levels in K562 cells following folate depletion Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School peak area
ST003347 AN005482 ADSL deficiency drives mitochondrial dysfunction and ERK2 dysregulation in a linear genotype to phenotype correlation Skin Human Neuropathy Catholic University of the Sacred Heart peak area
ST003499 AN005743 Metabolic analysis of ADSL deficiency patients' EBV-LCLs. Blood Human Mitochondrial Dysfunction Catholic University of the Sacred Heart peak area
ST003499 AN005744 Metabolic analysis of ADSL deficiency patients' EBV-LCLs. Blood Human Mitochondrial Dysfunction Catholic University of the Sacred Heart peak area
ST000301 AN000479 GBM Cell Lines Reproducibility Pilot Study Glioma cells Human University of Michigan Peak area
ST001218 AN002031 Wild type versus TRACK Mice on regular chow and Vitamin A deprived diet Kidney Mouse Cancer weill cornell medicine Peak area
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak area
ST001441 AN002408 Metabolomics of patient-derived fibroblasts Fibroblast cells Human Mitochondrial disease North Carolina State University Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Muscle Mouse Cancer North Carolina State University Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Sarcoma Mouse Cancer North Carolina State University Peak area
ST001621 AN002656 Untargeted metabolomics of intestinal organoids treated with fructose Intestine Mouse China Pharmaceutical University Peak area
ST001709 AN002784 SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition Cultured cells Human COVID-19 University of California, Los Angeles Peak area
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China Peak area
ST002508 AN004130 13C-isotopic labeling of mouse eye organoids under three conditions. Retina Mouse Northwestern University Peak area
ST002846 AN004664 Apolipoprotein E suppresses hyperlipidemia-driven hematopoiesis & inflammation by controlling mitochondrial metabolism Macrophages Mouse Hyperlipidemia Northwestern University Peak area
ST003249 AN005322 Mitochondrial respiration impairment in microglia dampens response to demyelinating injury but is not sufficient to induce an aging phenotype Microglia Mouse Alzheimers disease Northwestern University Peak area
ST003262 AN005346 A Covalent Creatine Kinase Inhibitor Ablates Glioblastoma Migration and Sensitizes Tumors to Oxidative Stress. Brain Human Cancer Northwestern University, Feinberg School of Medicine Peak area
ST001954 AN003179 A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia Yeast cells Yeast Friedreichs Ataxia University of California, Los Angeles Peak Area
ST002709 AN004391 FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer Cultured cells Other Cancer University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Diabetes University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Hypoglycemia University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Hypoglycemia; Diabetes University of California, Los Angeles Peak Area
ST002852 AN004673 MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer Prostate Mouse Cancer University of California, Los Angeles Peak Area
ST002878 AN004716 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. Embryonic cells Mouse Diabetes University of California, Los Angeles Peak Area
ST001170 AN001935 Timecourse on MCF-7 cells treated with different concentration of doxorubicin Cultured cells Human China Pharmaceutical University Peak area normalized
ST002499 AN004106 Metabolomics analysis of stress erythroid progenitors (Part 2) Stem cells Mouse Inflammation Pennsylvania State University peak area normalized to IS and cell number
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Adipose tissue Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Blood Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Heart Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Liver Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Muscle Mouse University of Michigan Peak area (normalized to tissue mass)
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Area Post-Blank Subtraction
ST002115 AN003513 LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells Cultured cells Human University of Texas MD Anderson Cancer Center Peak area (top)
ST002412 AN003931 Metabolic effects of the protein kinase R Macrophages Mouse Hudson peak height
ST002926 AN004799 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University peak height
ST003053 AN005007 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University peak height
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001276 AN002117 Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST003179 AN005222 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University Peak height
ST001201 AN001999 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001201 AN001999 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001547 AN002577 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University Peak intensity
ST001549 AN002581 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST001652 AN002699 Atypical Molecular Basis for Drug Resistance to Mitochondrial AQ: A Function Inhibitors in Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria U.S. Food & Drug Administration Peak intensity
ST002595 AN004267 MoTrPAC: Endurance exercise training study in young adult rats, Rat Gastrocnemius Powder - Targeted Nucleotides Gastrocnemius Rat Duke University pmol/mg of tissue
ST002601 AN004273 MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Targeted Nucleotides Heart Rat Duke University pmol/mg of tissue
ST002615 AN004287 MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Targeted Nucleotides Liver Rat Duke University pmol/mg of tissue
ST002625 AN004297 MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Targeted Nucleotides White adipose Rat Duke University pmol/mg of tissue
ST001759 AN002866 Application of the redox metabolite detection method for mouse liver Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001760 AN002867 Application of the redox metabolite detection method for mouse kidney Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001761 AN002868 Application of the redox metabolite detection method for mouse biofluids Cerebrospinal fluid Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001762 AN002869 Application of the redox metabolite detection method for mouse kidney (part II) Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001763 AN002870 Application of the redox metabolite detection method for mouse liver (part II) Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001764 AN002871 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbation with methotrexate Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001765 AN002872 Optimization of redox metabolite detection in mammalian cells (part I) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001766 AN002873 Application of the redox metabolite detection method for mammalian tissues (part I) Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001766 AN002873 Application of the redox metabolite detection method for mammalian tissues (part I) Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001768 AN002875 Application of the redox metabolite detection method for mammalian tissues (part III) Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001768 AN002875 Application of the redox metabolite detection method for mammalian tissues (part III) Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001769 AN002876 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part I) Cultured cells Human Boston Childrens Hospital ppm
ST001771 AN002878 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part III) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001772 AN002879 Optimization of redox metabolite detection in mammalian cells (part II) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001773 AN002880 Application of the redox metabolite detection method for mouse biofluids (part II) Blood Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001974 AN003222 Anti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (I) Cerebrospinal fluid Mouse Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001975 AN003223 Anti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (II) Cerebrospinal fluid Mouse Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001976 AN003224 Anti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (III) Cerebrospinal fluid Mouse Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001977 AN003225 Anti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (IV) Cerebrospinal fluid Human Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001978 AN003226 Anti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (V) Cerebrospinal fluid Human Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001979 AN003228 Anti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (VI) Cerebrospinal fluid Mouse Cancer Boston Children's Hospital, Harvard Medical School ppm
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST002584 AN004255 Metabolomics analysis of ALDH1L1-expressing HuH7 cell lines. Cultured cells Human Cancer Tohoku Medical and Pharmaceutical University relative area
ST001167 AN001930 Comprehensive Profiling by Non-targeted Stable Isotope Tracing Capillary Electrophoresis-Mass Spectrometry Cultured cells Human Cancer Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences Relative intensity after normalization
ST002729 AN004423 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Muscle Mouse Diabetes Medical Institute of Bioregulation, Kyushu University relative peak area
ST001304 AN002173 Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii Fibroblast cells Toxoplasma gondii Parasitic infection Monash University Signal Intensity
ST003297 AN005401 Metabolomic profiling of cultured TRAMP-C2 cells in the presence or absence of PD-L1. Cultured cells Mouse Cancer University of Ottawa uM
  logo